Cita APA

Chen, X., Du, F., Hong, R., Wang, J., Luo, Y., Li, Q., . . . Xu, B. (2016). Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer. Chin J Cancer.

Chicago Style Citation

Chen, Xue-Lian, Feng Du, Ruo-Xi Hong, Jia-Yu Wang, Yang Luo, Qing Li, Ying Fan, i Bing-He Xu. "Hormonal Therapy Might Be a Better Choice As Maintenance Treatment Than Capecitabine After Response to First-line Capecitabine-based Combination Chemotherapy for Patients With Hormone Receptor-positive and HER2-negative, Metastatic Breast Cancer." Chin J Cancer 2016.

Cita MLA

Chen, Xue-Lian, et al. "Hormonal Therapy Might Be a Better Choice As Maintenance Treatment Than Capecitabine After Response to First-line Capecitabine-based Combination Chemotherapy for Patients With Hormone Receptor-positive and HER2-negative, Metastatic Breast Cancer." Chin J Cancer 2016.